Background illustration for clinical trials search

Paid Clinical Trials Pennsylvania

Discover 3,059 paid clinical trials in Pennsylvania. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

for
Thrombocytopenia, Neonatal Alloimmune
Location: Philadelphia PA, Rochester NY, Chapel Hill NC,
Sponsor: Janssen Research & Development, LLC

Sex: Female

Age: 18 - 45

Code: NCT06533098

Phase 3, Recruiting

Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study

for
Atrial Fibrillation (AF)
Location: Valhalla NY, Philadelphia PA, Jacksonville FL, Tampa FL,
Sponsor: Vektor Medical

Sex: All

Age: 22+

Code: NCT06935591

Recruiting

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

for
Colorectal Neoplasms
Location: Shirley NY, New Haven CT, Mineola NY, The Bronx NY,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06662786

Phase 3, Recruiting

A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

for
Type 1 Diabetes Mellitus
Location: Halifax, New Haven CT, New York NY, Philadelphia PA,
Sponsor: Sanofi

Sex: All

Age: 1 - 25

Code: NCT07088068

Phase 3, Recruiting

Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodularis in Adults

for
Prurigo Nodularis
Location: Portsmouth NH, Brighton MA, Fairfield CT,
Sponsor: Galderma R&D

Sex: All

Age: 18+

Code: NCT06988618

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety

for
Epileptic Encephalopathy, SCN2A Encephalopathy
Location: Philadelphia PA, Cincinnati OH, Chicago IL, Memphis TN,
Sponsor: Praxis Precision Medicines

Sex: All

Age: 0 - 18

Code: NCT07019922

Phase 3, Recruiting

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

for
Ulcerative Colitis, Obesity or Overweight
Location: London, New Bedford MA, Providence RI, Lebanon NH,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70

Code: NCT06937086

Phase 3, Recruiting

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

for
Crohn's Disease, Obesity or Overweight
Location: London, New Bedford MA, Providence RI, Lebanon NH,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70

Code: NCT06937099

Phase 3, Recruiting

BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)

for
Advanced Malignancies, Ovarian Cancer, T-cell Lymphoma,
Location: New York NY, Philadelphia PA, Duarte CA
Sponsor: BioInvent International AB

Sex: All

Age: 18+

Code: NCT04752826

Phase 1, Phase 2, Recruiting

A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine

for
Advanced High-Grade Epithelial Ovarian Cancer,
Location: Worcester MA, Pittsburgh PA, Sarasota FL, Detroit MI,
Sponsor: AbbVie

Sex: Female

Age: 18+

Code: NCT06682988

Phase 2, Recruiting

Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Acute Sinusitis

for
Sinus Infection, Acute Sinusitis
Location: Hershey PA, Washington D.C. DC, Richmond VA, Madison WI,
Sponsor: Daniel Merenstein

Sex: All

Age: 18 - 70+

Code: NCT06076304

Recruiting

Zelenectide Pevedotin in NECTIN4 Amplified Advanced or Metastatic Non-small Cell Lung Cancer

for
Non-Small Cell Lung Cancer
Location: Boston MA, Philadelphia PA, Arlington VA, Fairfield OH,
Sponsor: BicycleTx Limited

Sex: All

Age: 18+

Code: NCT06933329

Phase 2, Recruiting

A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma

for
Plasmablastic Lymphoma,
Location: New York NY, Philadelphia PA, Baltimore MD,
Sponsor: AIDS Malignancy Consortium

Sex: All

Age: 18+

Code: NCT04139304

Early Phase 1, Recruiting

A Global Study of the PETAL Consortium

for
T-Cell and NK-Cell Neoplasm
Location: Boston MA, Hackensack NJ, Philadelphia PA,
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT06067347

Recruiting

Home Blood Transfusions

for
Hematologic Malignancy, Myelodysplastic Syndromes,
Location: Philadelphia PA
Sponsor: Thomas Jefferson University

Sex: All

Age: 18+

Code: NCT07121140

Recruiting

A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

for
Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma
Location: Boston MA, Lake Success NY, New York NY,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06876662

Recruiting

Impact of Prehabilitation in Oncology Via Exercise- Esophageal (IMPROVE-Esophageal)

for
Esophageal Cancer, Esophageal Carcinoma
Location: Pittsburgh PA
Sponsor: University of Pittsburgh

Sex: All

Age: 18+

Code: NCT06872515

Recruiting

Identification of Breast Cancer in Breath Samples Using Trained Detection Dogs

for
Breast Cancer
Location: Totowa NJ, Philadelphia PA
Sponsor: SpotitEarly

Sex: Female

Age: 18+

Code: NCT07038785

Recruiting

Myriad™ Augmented Soft Tissue Reconstruction Registry

for
Abdominal Wound Dehiscence, Necrotizing Soft Tissue Infection,
Location: Lancaster PA, Baltimore MD, Gainesville GA,
Sponsor: Aroa Biosurgery Limited

Sex: All

Age: 18+

Code: NCT05243966

Recruiting

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: St. John's, Halifax, Bangor ME, Scarborough ME,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 30

Code: NCT04546399

Phase 2, Recruiting

Popular cities in Pennsylvania